| 3198 |
55: Cell injury/death |
177: Increase, Mitochondrial dysfunction |
Apr 17, 2024 |
Apr 17, 2024 |
None
|
| 3244 |
55: Cell injury/death |
2084: Increase, Cardiac remodelling |
Jun 4, 2024 |
Jun 4, 2024 |
1 AOP
|
| 3245 |
55: Cell injury/death |
1532: Decrease, Cardiac contractility |
Jun 4, 2024 |
Jun 4, 2024 |
1 AOP
|
| 2215 |
1825: Increase, Cell death |
1521: Decrease, Growth |
Dec 4, 2020 |
Dec 4, 2020 |
1 AOP
|
| 2467 |
1825: Increase, Cell death |
1930: Altered, inner ear development |
Aug 23, 2021 |
Aug 29, 2021 |
1 AOP
|
| 2489 |
1825: Increase, Cell death |
1931: Disruption of the intestinal barrier |
Oct 19, 2021 |
Oct 19, 2021 |
None
|
| 2706 |
1825: Increase, Cell death |
896: Parkinsonian motor deficits |
Jul 25, 2022 |
Jul 25, 2022 |
1 AOP
|
| 2718 |
1825: Increase, Cell death |
188: Neuroinflammation |
Jul 25, 2022 |
Jul 25, 2022 |
None
|
| 2760 |
1825: Increase, Cell death |
1496: Increased proinflammatory mediators |
Sep 1, 2022 |
Sep 1, 2022 |
1 AOP
|
| 2842 |
1825: Increase, Cell death |
2089: Altered Bone Cell Homeostasis |
Jan 25, 2023 |
Nov 6, 2024 |
1 AOP
|
| 2863 |
1825: Increase, Cell death |
758: Hippocampal Physiology, Altered |
Apr 3, 2023 |
Apr 3, 2023 |
None
|
| 3504 |
1825: Increase, Cell death |
2312: Increased, nasal lesions |
Mar 5, 2025 |
Mar 19, 2025 |
1 AOP
|
| 3507 |
1825: Increase, Cell death |
2316: Increased, pulmonary edema |
Mar 12, 2025 |
Mar 24, 2025 |
1 AOP
|
| 3508 |
1825: Increase, Cell death |
2317: Loss of olfactory function |
Mar 13, 2025 |
Mar 25, 2025 |
1 AOP
|
| 3765 |
1825: Increase, Cell death |
1097: Occurrence, renal proximal tubular necrosis |
Mar 29, 2026 |
Mar 29, 2026 |
1 AOP
|
| 2112 |
1779: Increase, Casp transcription (F3) |
1780: Increase, Oocyte apoptosis (F3) |
Apr 30, 2020 |
Apr 30, 2020 |
1 AOP
|
| 2116 |
1779: Increase, Casp transcription (F3) |
1783: Increase, Ovarian somatic cell apoptosis (F3) |
Apr 30, 2020 |
Apr 30, 2020 |
1 AOP
|
| 2103 |
1774: Increase, Casp transcription |
1775: Increase, Oocyte apoptosis |
Apr 30, 2020 |
Apr 30, 2020 |
2 AOPs
|
| 2105 |
1774: Increase, Casp transcription |
1776: Increase, Ovarian somatic cell apoptosis |
Apr 30, 2020 |
Apr 30, 2020 |
1 AOP
|
| 3175 |
2084: Increase, Cardiac remodelling |
2215: Decrease LV function |
Apr 3, 2024 |
Apr 3, 2024 |
1 AOP
|
| 60 |
50: Increase, Ca++ (intracellular) |
178: Mitochondrial electron transport chain, disrupted |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2845 |
2090: Bone Remodeling |
2091: Bone Loss |
Jan 25, 2023 |
Aug 9, 2024 |
1 AOP
|
| 2741 |
2048: Increase, Body volume of female adults |
2050: Increase, developmental abnormalities |
Aug 28, 2022 |
Aug 28, 2022 |
1 AOP
|
| 2092 |
1769: Increase, Body fluid overload |
350: Increase, Mortality |
Apr 30, 2020 |
Apr 30, 2020 |
1 AOP
|
| 2236 |
401: Increase, Biliary excretion TH glucuronide |
281: T4 in serum, Decreased |
Dec 9, 2020 |
Dec 9, 2020 |
None
|